Neublastin variants

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 14/475 (2006.01) A61K 38/17 (2006.01) A61K 47/48 (2006.01) C07K 17/08 (2006.01) C07K 19/00 (2006.01) C12N 15/18 (2006.01)

Patent

CA 2577755

Variant Neublastin polypeptides having substitutions at selected amino acid residues are disclosed. Substitution at one or more selected amino acid residues decreases heparin binding and increases serum exposure of variant Neublastin polypeptides. Also disclosed are methods of using variant Neublastin polypeptides to treat disorders and activate the RET receptor in a mammal.

L'invention concerne des polypeptides variants de neublastine présentant des substitutions au niveau de résidus d'acides aminés sélectionnés. La substitution au niveau d'un ou de plusieurs résidus d'acides aminés sélectionnés diminue la liaison à l'héparine et augmente l'exposition sérique de polypeptides variants de neublastine. L'invention concerne également des méthodes d'utilisation de polypeptides variants de neublastine pour traiter des troubles et activer le récepteur RET chez un mammifère.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Neublastin variants does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Neublastin variants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neublastin variants will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1364157

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.